We are live on ! Find out more
PSTX

Poseida Therapeutics, Inc. Common Stock
PSTX

Delisted

PSTX was delisted on the 7th of January, 2025.

Back to rankings

1 hedge funds and large institutions have $308K invested in Poseida Therapeutics, Inc. Common Stock in 2025 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 113 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 115 → 1 (-114)

100% less capital invested

Capital invested by funds: $519M → $308K (-$519M)

100% less funds holding in top 10

Funds holding in top 10: 2 → 0 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 113

Holders
1
Holders Change
-114
Holders Change %
-99.13%
% of All Funds
0.01%
Holding in Top 10
–
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
113
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$96.1M
2
PCM
Pentwater Capital Management
Florida
-$82.8M
3
BlackRock
BlackRock
New York
-$54.1M
4
Nomura Holdings
Nomura Holdings
Japan
-$49.1M
5
Vanguard Group
Vanguard Group
Pennsylvania
-$36.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
CIEC
51
Crédit Industriel et Commercial
France
– -$768K -80,000 Closed
HM
52
Harvest Management
New York
– -$768K -80,000 Closed
XT
53
XTX Topco
Cayman Islands
– -$682K -71,040 Closed
RC
54
RBF Capital
California
– -$674K -70,171 Closed
SO
55
STRS Ohio
Ohio
– -$646K -67,300 Closed
AllianceBernstein
56
AllianceBernstein
Tennessee
– -$614K -63,970 Closed
QOP
57
Quinn Opportunity Partners
Virginia
– -$559K -58,227 Closed
State of Wisconsin Investment Board
58
State of Wisconsin Investment Board
Wisconsin
– -$535K -55,700 Closed
Citigroup
59
Citigroup
New York
– -$517K -53,844 Closed
FLC
60
Fifth Lane Capital
Texas
– -$481K -50,100 Closed
Deutsche Bank
61
Deutsche Bank
Germany
– -$461K -47,985 Closed
JIC
62
Johnson Investment Counsel
Ohio
– -$419K -43,600 Closed
MA
63
MCF Advisors
Kentucky
– -$411K -42,854 Closed
MIM
64
MetLife Investment Management
New Jersey
– -$404K -42,083 Closed
American Century Companies
65
American Century Companies
Missouri
– -$404K -42,073 Closed
Wells Fargo
66
Wells Fargo
California
– -$364K -37,955 Closed
BNP Paribas Financial Markets
67
BNP Paribas Financial Markets
France
– -$363K -37,763 Closed
Jane Street
68
Jane Street
New York
– -$340K -35,452 Closed
CF
69
Corebridge Financial
Texas
– -$328K -34,132 Closed
SG Americas Securities
70
SG Americas Securities
New York
– -$294K -30,623 Closed
Invesco
71
Invesco
Georgia
– -$286K -29,797 Closed
T. Rowe Price Associates
72
T. Rowe Price Associates
Maryland
– -$266K -27,677 Closed
Manulife (Manufacturers Life Insurance)
73
Manulife (Manufacturers Life Insurance)
Ontario, Canada
– -$244K -25,455 Closed
New York State Common Retirement Fund
74
New York State Common Retirement Fund
New York
– -$219K -22,771 Closed
Franklin Resources
75
Franklin Resources
California
– -$212K -22,039 Closed
1 2
3
4 5

PSTX Hedge Fund Activity: Q1 2025 in Review

1 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Poseida Therapeutics, Inc. Common Stock (PSTX) for Q1 2025, worth a combined $308K — down 100% from $519M a quarter earlier.

Sellers outnumbered buyers: 113 funds closed out of PSTX and 0 opened new positions — a net loss of 113 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Fidelity Investments, exiting entirely with an estimated $96.1M sold.

  • 1 institutional investor held Poseida Therapeutics, Inc. Common Stock (PSTX) as of Q1 2025, down from 115 in Q4 2024.
  • Funds reported $308K of Poseida Therapeutics, Inc. Common Stock stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Poseida Therapeutics, Inc. Common Stock positions in Q1 2025 and 113 closed out, a net change of -113 holders.
  • The largest Poseida Therapeutics, Inc. Common Stock seller in Q1 2025 was Fidelity Investments, an estimated $96.1M sold.

Based on aggregated 13F filings for Q1 2025.